Fluroxene mutagenicity.
The commercially available volatile anesthetic fluroxene (2,2,2-trifluoroethyl vinyl ether) which contains the stabilizer N-phenyl-1-napthylamine, was tested for mutagenicity using four strains of S. typhimurium, TA1535, TA1537, TA98 and TA100, and one strain of E. coli, WP2. In addition, purified fluroxene; N-phenyl-1-napthylamine; trifluoroethanol, a major metabolite of fluoroxene; and urine from rats anesthetized with fluroxene were tested. Several procedures were utilized including exposure of bacteria to vapor in desiccators and in liquid suspension. Results indicate that fluroxene, but not its stabilizer, was mutagenic to strains TA1535, TA100 and WP2 only in liquid suspension and only in the presence of a rat-liver enzyme system. Trifluoroethanol and urine from fluroxene-treated rat were not mutagenic to any strain of bacteria. These findings indicate that fluroxene is a promutagen which requires preincubation before it is recognized. Further experiments were performed with enzymes prepared from mouse, hamster and human liver. Fluroxene was mutagenic only in the presence of enzymes prepared from Aroclor 1254 pretreated rodents. Since fluroxene was not mutagenic in the presence of enzymes prepared from three human livers, the significance of these findings to man are unclear.
D000818:Animals; D006224:Cricetinae; D004926:Escherichia coli / Q000235:genetics; D004987:Ethers / Q000494:pharmacology*; D005821:Genetic Techniques; D006801:Humans; D051379:Mice; D009153:Mutagens; D010088:Oxidoreductases / Q000378:metabolism; D051381:Rats; D012486:Salmonella typhimurium / Q000235:genetics; D013045:Species Specificity
D004987:Ethers; D009153:Mutagens; D010088:Oxidoreductases